Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date08 Sep 1986 |
100 Clinical Results associated with Guangdong Maiheng Pharmaceutical R&D Co., Ltd.
0 Patents (Medical) associated with Guangdong Maiheng Pharmaceutical R&D Co., Ltd.
100 Deals associated with Guangdong Maiheng Pharmaceutical R&D Co., Ltd.
100 Translational Medicine associated with Guangdong Maiheng Pharmaceutical R&D Co., Ltd.